Boai NKY Pharmaceuticals Ltd (300109) — Financial Flexibility Index
Boai NKY Pharmaceuticals Ltd (300109) has a Financial Flexibility Index of 0.33x as of September 2025. Free cash flow of CN¥180.87 Million (operating CF CN¥139.46 Million minus capex CN¥41.41 Million) represents 0% of total liabilities (CN¥552.11 Million). Check 300109 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Boai NKY Pharmaceuticals Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Boai NKY Pharmaceuticals Ltd across 19 annual periods. See Boai NKY Pharmaceuticals Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Boai NKY Pharmaceuticals Ltd. For the full company profile including market capitalisation, see 300109 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥558.53 Million | CN¥338.11 Million | CN¥713.16 Million | ▲ +12.8% |
| 2024 | 0.69x | CN¥530.72 Million | CN¥256.03 Million | CN¥764.37 Million | ▼ -59.9% |
| 2023 | 1.73x | CN¥866.14 Million | CN¥488.25 Million | CN¥499.66 Million | ▲ +99.6% |
| 2022 | 0.87x | CN¥517.77 Million | CN¥251.77 Million | CN¥596.29 Million | ▲ +88.4% |
| 2021 | 0.46x | CN¥271.76 Million | CN¥43.44 Million | CN¥589.76 Million | ▲ +34.6% |
| 2020 | 0.34x | CN¥366.11 Million | CN¥266.87 Million | CN¥1.07 Billion | ▲ +76.5% |
| 2019 | 0.19x | CN¥221.99 Million | CN¥79.64 Million | CN¥1.14 Billion | ▲ +15.0% |
| 2018 | 0.17x | CN¥173.18 Million | CN¥48.81 Million | CN¥1.03 Billion | ▼ -37.3% |
| 2017 | 0.27x | CN¥176.51 Million | CN¥47.28 Million | CN¥656.22 Million | ▼ -86.2% |
| 2016 | 1.95x | CN¥162.61 Million | CN¥114.14 Million | CN¥83.32 Million | ▲ +36.4% |
| 2015 | 1.43x | CN¥104.59 Million | CN¥64.12 Million | CN¥73.11 Million | ▲ +13.6% |
| 2014 | 1.26x | CN¥93.71 Million | CN¥46.60 Million | CN¥74.38 Million | ▼ -2.1% |
| 2013 | 1.29x | CN¥58.65 Million | CN¥23.17 Million | CN¥45.58 Million | ▼ -47.2% |
| 2012 | 2.44x | CN¥111.61 Million | CN¥20.65 Million | CN¥45.81 Million | ▼ -12.7% |
| 2011 | 2.79x | CN¥108.24 Million | CN¥3.94 Million | CN¥38.80 Million | ▲ +118.3% |
| 2010 | 1.28x | CN¥31.43 Million | CN¥10.05 Million | CN¥24.60 Million | ▲ +15.5% |
| 2009 | 1.11x | CN¥53.84 Million | CN¥28.57 Million | CN¥48.66 Million | ▲ +864.4% |
| 2008 | 0.11x | CN¥5.45 Million | CN¥-4.09 Million | CN¥47.52 Million | ▼ -60.9% |
| 2007 | 0.29x | CN¥14.33 Million | CN¥9.56 Million | CN¥48.84 Million | — |